Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Photobiomodulation on NMES-Induced Muscle Fatigue and Damage

26. august 2026 oppdatert av: Marco Aurélio Vaz, PhD, Federal University of Rio Grande do Sul

Effects of Photobiomodulation and Stimulation Sites on Muscle Fatigue and Damage Induced by Neuromuscular Electrical Stimulation in Healthy Individuals

Neuromuscular electrical stimulation (NMES) is effective for strength training and rehabilitation, but non-selective motor unit recruitment often induces rapid fatigue, discomfort, and muscle damage. Photobiomodulation therapy (PBMT) has been proposed to attenuate muscle fatigue and accelerate recovery, yet evidence regarding its acute prophylactic effects against NMES-induced fatigue remains limited. This randomized, single-blind, sham-controlled crossover pilot trial evaluates the acute effects of pre-exercise PBMT on knee extensor neuromuscular fatigability, muscle damage, discomfort, and functional recovery following a standardized NMES fatigue protocol in healthy adults.

Studieoversikt

Status

Fullført

Forhold

Intervensjon / Behandling

Detaljert beskrivelse

This study utilizes a randomized, single-blind, sham-controlled crossover design to evaluate the acute effects of photobiomodulation therapy (PBMT) on neuromuscular electrical stimulation (NMES)-induced fatigue in healthy individuals.

Participants undergo testing across two intervention blocks separated by a 7-day washout period between limbs:

Intervention Phase: Five minutes prior to an electrically evoked fatigue protocol, participants receive either active PBMT (multi-diode GaAlAs laser cluster; 810 nm; 200 mW per diode; 30 J per point across 8 quadriceps sites; total energy dose: 240 J) or sham PBMT (identical positioning with the device inactive and acoustic blinding).

NMES Fatigue Protocol: The protocol is performed on an isokinetic dynamometer with the knee fixed at 90° flexion. Rectangular biphasic symmetrical pulses (100 Hz; 1 ms pulse width; 5 s on, 10 s off) are delivered over 20 minutes to evoke 60 isometric contractions adjusted to an initial torque of 20% maximal voluntary isometric contraction (MVIC).

Evaluation Timeline: Neuromuscular and functional assessments are conducted at Baseline, Immediately Post-Fatigue, and at 24, 48, and 72 hours post-protocol. Tests include maximal voluntary isometric torque, resting supramaximal evoked twitches, transverse ultrasound echointensity of the rectus femoris and vastus lateralis, pressure pain thresholds via algometry, Visual Analog Scales for discomfort, and horizontal Single Hop Test performance.

Studietype

Intervensjonell

Registrering (Faktiske)

12

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Rio Grande do Sul
      • Porto Alegre, Rio Grande do Sul, Brasil, 90690200
        • Laboratório de Pesquisa do Exercício

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen

Tar imot friske frivillige

Ja

Beskrivelse

Inclusion Criteria:

  • Healthy male and female adults aged between 18 and 40 years.
  • Engaging in regular physical activity (minimum of twice a week).
  • No history of hospitalization for COVID-19 in the past 12 months.
  • Demonstrated ability to tolerate neuromuscular electrical stimulation (NMES).
  • Capable of fully understanding and complying with the experimental protocol and procedures.

Exclusion Criteria:

  • Presence of any sensory impairments or neurological alterations.
  • Ingestion of caffeine, coffee, energy drinks, or other stimulants in the 12 hours preceding the testing sessions.
  • Body Mass Index (BMI) greater than 30 kg/m².
  • Any medical contraindication to performing maximal physical exertion or presenting an abnormal cardiovascular/blood pressure response after maximal effort.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Grunnvitenskap
  • Tildeling: Randomisert
  • Intervensjonsmodell: Crossover-oppdrag
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Active PBMT + NMES
Participants receive active Photobiomodulation Therapy (PBMT) applied to the knee extensor muscles 5 minutes prior to undergoing a 20-minute neuromuscular electrical stimulation (NMES) fatigue protocol on the randomized lower limb.
Multi-diode cluster probe (GaAlAs laser; 5 diodes; wavelength: 810 nm; power output: 200 mW per diode; continuous mode) applied across 8 points over the quadriceps femoris (3 on rectus femoris, 3 on vastus lateralis, and 2 on vastus medialis) for 30 seconds per point (30 J/point), delivering a total energy dose of 240 J per limb.
Sham-komparator: Sham PBMT + NMES
Participants receive sham Photobiomodulation Therapy (device turned off, identical positioning and acoustic blinding) applied to the knee extensor muscles 5 minutes prior to undergoing a 20-minute neuromuscular electrical stimulation (NMES) fatigue protocol on the contralateral lower limb.
Identical probe positioning over the 8 quadriceps locations for 30 seconds per point with the laser device completely turned off. Auditory headphones are used to blind participants against sound cues.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Maximal Voluntary Isometric Contraction (MVIC) Torque
Tidsramme: Baseline, Immediately post-fatigue protocol, 24 hours, 48 hours, and 72 hours post-fatigue.
Knee extensor peak isometric torque measured on an isokinetic dynamometer (Biodex System 3 Pro) during 5-second maximal isometric contractions with the knee fixed at 90° flexion, expressed in Newton-meters (N.m).
Baseline, Immediately post-fatigue protocol, 24 hours, 48 hours, and 72 hours post-fatigue.

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Muscle Damage via Ultrasound Echointensity
Tidsramme: Baseline, Immediately post-fatigue protocol, 24 hours, 48 hours, and 72 hours post-fatigue.
Quantitative grayscale histogram analysis (0 = black, 255 = white) of transverse ultrasound images (ImageJ software) of the rectus femoris (at 40%, 50%, and 60% of the femur length) and vastus lateralis (at 50% of the femur length) muscles to assess structural muscle damage.
Baseline, Immediately post-fatigue protocol, 24 hours, 48 hours, and 72 hours post-fatigue.
Supramaximal Evoked Twitch Torque
Tidsramme: Baseline, Immediately post-fatigue protocol, 24 hours, 48 hours, and 72 hours post-fatigue.
Knee extensor evoked torque produced by single supramaximal electrical twitches (1 Hz, 500 µs rectangular biphasic pulses at rest) delivered to the rectus femoris motor point, measured in Newton-meters (N.m) on the isokinetic dynamometer to evaluate peripheral muscle fatigue.
Baseline, Immediately post-fatigue protocol, 24 hours, 48 hours, and 72 hours post-fatigue.
Evoked Neuromuscular Efficiency
Tidsramme: Baseline, Immediately post-fatigue protocol, 24 hours, 48 hours, and 72 hours post-fatigue.
Ratio between the supramaximal evoked twitch peak torque and the applied current intensity (Nm/mA) during resting single pulses.
Baseline, Immediately post-fatigue protocol, 24 hours, 48 hours, and 72 hours post-fatigue.
Sitting Muscle Discomfort
Tidsramme: Baseline, Immediately post-fatigue protocol, 24 hours, 48 hours, and 72 hours post-fatigue.
Subjective sensation of discomfort/pain in the quadriceps femoris evaluated while seated at rest using a 10 cm Visual Analog Scale (VAS), where 0 cm represents 'no discomfort' and 10 cm represents 'maximum discomfort'.
Baseline, Immediately post-fatigue protocol, 24 hours, 48 hours, and 72 hours post-fatigue.
Pain Pressure Threshold (PPT)
Tidsramme: Baseline, Immediately post-fatigue protocol, 24 hours, 48 hours, and 72 hours post-fatigue.
Mechanical pain sensitivity measured using a digital pressure algometer (applied at 90° in kgf/cm²) over the rectus femoris, vastus lateralis, and vastus medialis muscle bellies to identify delayed onset muscle soreness.
Baseline, Immediately post-fatigue protocol, 24 hours, 48 hours, and 72 hours post-fatigue.
Single Hop Test (SHT) Functional Performance
Tidsramme: Baseline, Immediately post-fatigue protocol, 24 hours, 48 hours, and 72 hours post-fatigue.
Maximal horizontal single-leg hop distance normalized to limb length, calculated as: [Hop Distance (cm) / Limb Length (cm)] * 100.
Baseline, Immediately post-fatigue protocol, 24 hours, 48 hours, and 72 hours post-fatigue.
Discomfort During Stair Ascent and Descent
Tidsramme: Baseline, Immediately post-fatigue protocol, 24 hours, 48 hours, and 72 hours post-fatigue.
Level of discomfort reported on a 10 cm Visual Analog Scale (VAS) immediately after ascending and descending a 10-step staircase.
Baseline, Immediately post-fatigue protocol, 24 hours, 48 hours, and 72 hours post-fatigue.
Total Mechanical Work During Fatigue Protocol
Tidsramme: During the 20-minute NMES fatigue protocol.
Cumulative mechanical work quantified by the sum of the torque-time integral (TTI) across all 60 evoked contractions during the 20-minute NMES protocol (expressed in N.m.s).
During the 20-minute NMES fatigue protocol.
Fatigue Index (% Work Decline)
Tidsramme: During the 20-minute NMES fatigue protocol.
Percentage reduction in work performed between the first 5 evoked contractions and the last 5 evoked contractions of the NMES fatigue protocol, calculated as: [(Initial Work - Final Work) / Initial Work] * 100.
During the 20-minute NMES fatigue protocol.

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Samarbeidspartnere

Etterforskere

  • Studiestol: Marco A Vaz, PhD, Federal University of Rio Grande do Sul
  • Hovedetterforsker: Marco A Vaz, PhD, Federal University of Rio Grande do Sul

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

1. november 2022

Primær fullføring (Faktiske)

1. august 2023

Studiet fullført (Faktiske)

1. desember 2023

Datoer for studieregistrering

Først innsendt

24. august 2026

Først innsendt som oppfylte QC-kriteriene

24. august 2026

Først lagt ut (Faktiske)

27. august 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

31. august 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

26. august 2026

Sist bekreftet

1. august 2026

Mer informasjon

Begreper knyttet til denne studien

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • 56181622.4.0000.5347

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

UBESLUTTE

IPD-planbeskrivelse

Individual participant data will not be publicly shared to protect participant confidentiality in accordance with the local ethics committee approval.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .